April 7, 2017: Here are four stocks trading with relatively heavy volume among 60 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 8 to 7 and on the Nasdaq advancers and decliners traded evenly, 1,400 to 1,409.
DryShips Inc. (NASDAQ: DRYS) dropped about 30% Friday to post a new 52-week low of $0.72 after closing at $1.03 on Thursday.....More>>>
A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.
Shares of Ceragon Networks (NASDAQ:CRNT) fell 11.1% in March 2017, according to data from S&P Global Market Intelligence.
At the end of February, Ceragon shares had posted 234% of gains in the previous 52 weeks. The maker of microwave-based networking equipment had no significant news to share in March, and investors should count themselves lucky....More>>>
Some lucky investors just struck gold at Northern Dynasty Minerals. Image source: Getty Images.
The past six months have seen shares of Northern Dynasty Minerals Ltd. (NYSEMKT:NAK) roughly quintuple in value, continually rising day to day from about $0.44 per share in July to today’s closing price $2.28.
Most days, Northern Dynasty shares have risen without....More>>>
Berkshire Hathaway Inc. (NYSE:BRK.A) is an American conglomerate with investments in a variety of businesses from American Express to Coca-Cola. It reported Q3 earnings last week, which were in line with analysts expectations, as the group revealed a 7% increase in operating profit compared to the same period last year.
Althoughthe group revealed mixed performance from its various subsidiaries,....More>>>
It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.
With a lot of sentiment and....More>>>